Learn More
Medchemexpress LLC HVH-2930 | 3034605-72-3 | 96.5% | 488.62 | 5 MG

Supplier: Medchemexpress LLC HY1617815MG
HVH-2930 is an inhibitor for heat shock protein 90 (HSP90). It inhibits the cell viability of BT474 (Trastuzumab sensitive) and JIMT-1 (Trastuzumab resistant) cells, with IC50 values of 6.86 μM and 4.42 μM, respectively. This inhibition is achieved through the downregulation of HSP90 client proteins. HVH-2930 has demonstrated antitumor efficacy in mouse models and possesses favorable pharmacokinetic characteristics in mice.
- Inhibits heat shock protein 90 (HSP90)
- Inhibits cell viability of BT474 and JIMT-1 cells
- Downregulates HSP90 client proteins
- Demonstrates antitumor efficacy in mouse models
- Possesses favorable pharmacokinetic characteristics in mice
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.